HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France Warns Supplements Can Interfere With Immune Response To COVID-19

Executive Summary

Dietary supplements containing certain plants can inhibit the immune response to COVID-19 and should not be taken by those showing symptoms of the virus, according to French regulator ANSES.

You may also be interested in...



Vitamin D Supplements For Children Present Overdose Risk, Say French Regulators

France's food and drug regulators say children should only be given vitamin D in approved drugs after cases were reported of overdose in infants linked to supplement use.

Hair Supplement Linked To Cases Of Severe Hepatitis In France

France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.

Many European Nations Not Advocating Supplement Use During COVID Pandemic

Analysis of 12 European countries shows most governments are not promoting the use of dietary supplements to support immunity during the COVID-19 pandemic.

Related Content

Topics

UsernamePublicRestriction

Register

LL1131867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel